Effect of Carob Molasse Pose Flour and Germ On Glycemic Response and Antioxidant Capacity
NCT ID: NCT06200272
Last Updated: 2025-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2023-12-01
2024-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Blood Glucose, Total Antioxidant Level (TAS), and Total Oxidant Level (TOS) values will be statistically evaluated in the blood samples of individuals who consume standard whole wheat bread and the test whole wheat bread developed by us. If the results are found to be statistically significant, consuming the bread produced will play an important role in preventing chronic diseases such as obesity, diabetes, and cardiovascular diseases.
On the other hand; by adding CMP and germ, which are not currently evaluated, to the bread formulation, this study not only contributes to the prevention of food waste and sustainability by using low-cost food industry by-products but also enables the development of a bread-type with high nutritional value in terms of antioxidant-rich active ingredients, vitamins and dietary fiber.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Consumption of Bread Types Made From Various Flours on Blood Glucose Fluctuations
NCT06288178
To Test the Effect of Selected Fibres and Flours in Flat Bread on Post-Prandial Blood Glucose and Insulin Responses in Healthy Indian Population
NCT02814357
Glycemic and Insulinemic Response of Durum Wheat Bread
NCT06152874
Glycemic and Hormone Responses After the Intake of Four Types of Bread.
NCT02653677
The Effect of Hazelnut Flour on Blood Glucose
NCT06382506
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test group with standard whole wheat breads (Germ and Carob Molasses Pulp added)
Bread will be produced by adding germ (obtained after processing the wheat grain), which has a high antioxidant capacity and is rich in vitamins and dietary fiber, and carob pulp (Carob Molasses Pulp, CMP), which is not considered waste after the production of carob molasses, to the formulation of wheat bread, which has been widely consumed in recent years.
Germ and Carob Molasses Pulp added standard whole wheat breads
Test bread (bread with soluble pulp added, bread with added germ, and bread with soluble pulp + germ added) containing 50 g carbohydrate, samples taken from all four types of bread were collected for moisture, ash, fiber, protein, fat, digestible carbohydrate, and antioxidant capacity analysis will be performed. This experimental group consists of the group that will eat the test bread.
Control group with standard whole wheat breads
control bread (whole wheat bread) made based on a standard recipe
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Germ and Carob Molasses Pulp added standard whole wheat breads
Test bread (bread with soluble pulp added, bread with added germ, and bread with soluble pulp + germ added) containing 50 g carbohydrate, samples taken from all four types of bread were collected for moisture, ash, fiber, protein, fat, digestible carbohydrate, and antioxidant capacity analysis will be performed. This experimental group consists of the group that will eat the test bread.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no prescription drugs and/or nutritional supplements
* no pregnant or lactating
* no alcohol or excessive alcohol consumption (\<2 drinks/day)
* no smoking,
* BMI value between 18.5-24.9 kg/m2
* no in the menstrual period for female individuals
* no gluten enteropathy
* no insulin resistance as a result of endocrinological examination and biochemical tests
* no allergic reaction to carob
* signed the Informed Volunteer Consent Form
* aged between 19 and 35 years.
Exclusion Criteria
* using prescription drugs and/or nutritional supplements
* being in pregnancy and lactation
* consuming excessive alcohol (\>2 drinks/day)
* smoking
* BMI value under 18.5 or above 24.9. kg/m2
* being in the menstrual period for female individuals
* having gluten enteropathy
* having insulin resistance as a result of endocrinological examination and biochemical tests
* having an allergic reaction to carob
* not signed the Informed Volunteer Form,
* aged under 19 years or above 35 years of age
19 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Toros University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eda Parlak
Asst. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yüksel Özdemir, Prof.
Role: PRINCIPAL_INVESTIGATOR
Head of Toros University Scientific Research Projects
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Toros University
Mersin, Yenişehir, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EDA-YL-EBRAR-TOROS-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.